BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carlyle BC, Trombetta BA, Arnold SE. Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias. Proteomes 2018;6:32. [PMID: 30200280 DOI: 10.3390/proteomes6030032] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Park JH, Kim OH, Kim KH, Hong HE, Seo H, Choi HJ, Ahn J, Lee TY, Kim SJ. Isolation of Secretome with Enhanced Antifibrotic Properties from miR-214-Transfected Adipose-Derived Stem Cells. J Korean Med Sci 2019;34:e273. [PMID: 31760709 DOI: 10.3346/jkms.2019.34.e273] [Reference Citation Analysis]
2 Khambati N, Olbrich L, Ellner J, Salgame P, Song R, Bijker EM. Host-Based Biomarkers in Saliva for the Diagnosis of Pulmonary Tuberculosis in Children: A Mini-Review. Front Pediatr 2021;9:756043. [PMID: 34760853 DOI: 10.3389/fped.2021.756043] [Reference Citation Analysis]
3 Hampel H, Cummings J, Blennow K, Gao P, Jack CR Jr, Vergallo A. Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat Rev Neurol 2021;17:580-9. [PMID: 34239130 DOI: 10.1038/s41582-021-00520-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jamjoom AAB, Rhodes J, Andrews PJD, Grant SGN. The synapse in traumatic brain injury. Brain 2021;144:18-31. [PMID: 33186462 DOI: 10.1093/brain/awaa321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Carlyle BC, Kandigian SE, Kreuzer J, Das S, Trombetta BA, Kuo Y, Bennett DA, Schneider JA, Petyuk VA, Kitchen RR, Morris R, Nairn AC, Hyman BT, Haas W, Arnold SE. Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics. Neurobiol Aging 2021;105:99-114. [PMID: 34052751 DOI: 10.1016/j.neurobiolaging.2021.04.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yu X, Lai S, Chen H, Chen M. Protein–protein interaction network with machine learning models and multiomics data reveal potential neurodegenerative disease-related proteins. Human Molecular Genetics 2020;29:1378-87. [DOI: 10.1093/hmg/ddaa065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
7 Hong HE, Kim OH, Kwak BJ, Choi HJ, Im KH, Ahn J, Kim SJ. Antioxidant action of hypoxic conditioned media from adipose-derived stem cells in the hepatic injury of expressing higher reactive oxygen species. Ann Surg Treat Res 2019;97:159-67. [PMID: 31620389 DOI: 10.4174/astr.2019.97.4.159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Veerabhadrappa B, Delaby C, Hirtz C, Vialaret J, Alcolea D, Lleó A, Fortea J, Santosh MS, Choubey S, Lehmann S. Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand? Crit Rev Clin Lab Sci 2020;57:99-113. [PMID: 31661652 DOI: 10.1080/10408363.2019.1678011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
9 Shen Y, Xun J, Song W, Wang Z, Wang J, Liu L, Zhang R, Qi T, Tang Y, Chen J, Sun J, Lu H. Discovery of Potential Plasma Biomarkers for Tuberculosis in HIV-Infected Patients by Data-Independent Acquisition-Based Quantitative Proteomics. Infect Drug Resist 2020;13:1185-96. [PMID: 32425558 DOI: 10.2147/IDR.S245460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Cline EN, Alvarez C, Duan J, Patrie SM. Online μSEC2-nRPLC-MS for Improved Sensitivity of Intact Protein Detection of IEF-Separated Nonhuman Primate Cerebrospinal Fluid Proteins. Anal Chem 2021;93:16741-50. [PMID: 34881887 DOI: 10.1021/acs.analchem.1c00396] [Reference Citation Analysis]
11 Qin T, Prins S, Groeneveld GJ, Van Westen G, de Vries HE, Wong YC, Bischoff LJM, de Lange ECM. Utility of Animal Models to Understand Human Alzheimer's Disease, Using the Mastermind Research Approach to Avoid Unnecessary Further Sacrifices of Animals. Int J Mol Sci 2020;21:E3158. [PMID: 32365768 DOI: 10.3390/ijms21093158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cho KC, Oh S, Wang Y, Rosenthal LS, Na CH, Zhang H. Evaluation of the Sensitivity and Reproducibility of Targeted Proteomic Analysis Using Data-Independent Acquisition for Serum and Cerebrospinal Fluid Proteins. J Proteome Res 2021. [PMID: 34384221 DOI: 10.1021/acs.jproteome.1c00238] [Reference Citation Analysis]
13 Sobolev VV, Mezentsev AV, Ziganshin RH, Soboleva AG, Denieva M, Korsunskaya IM, Svitich OA. LC-MS/MS analysis of lesional and normally looking psoriatic skin reveals significant changes in protein metabolism and RNA processing. PLoS One 2021;16:e0240956. [PMID: 34038424 DOI: 10.1371/journal.pone.0240956] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 van Steenoven I, Koel-Simmelink MJA, Vergouw LJM, Tijms BM, Piersma SR, Pham TV, Bridel C, Ferri GL, Cocco C, Noli B, Worley PF, Xiao MF, Xu D, Oeckl P, Otto M, van der Flier WM, de Jong FJ, Jimenez CR, Lemstra AW, Teunissen CE. Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach. Mol Neurodegener 2020;15:36. [PMID: 32552841 DOI: 10.1186/s13024-020-00388-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
15 Rastogi S, Sharma V, Bharti PS, Rani K, Modi GP, Nikolajeff F, Kumar S. The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis. Int J Mol Sci 2021;22:E440. [PMID: 33406804 DOI: 10.3390/ijms22010440] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
16 Liu RX, Thiessen-Philbrook HR, Vasan RS, Coresh J, Ganz P, Bonventre JV, Kimmel PL, Parikh CR. Comparison of proteomic methods in evaluating biomarker-AKI associations in cardiac surgery patients. Transl Res 2021:S1931-5244(21)00162-6. [PMID: 34343625 DOI: 10.1016/j.trsl.2021.07.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Thompson AG, Oeckl P, Feneberg E, Bowser R, Otto M, Fischer R, Kessler B, Turner MR. Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis. Expert Rev Proteomics 2021;18:977-94. [PMID: 34758687 DOI: 10.1080/14789450.2021.2004890] [Reference Citation Analysis]
18 Agrawal I, Tripathi P, Biswas S. Mass Spectrometry Based Protein Biomarkers and Drug Target Discovery and Clinical Diagnosis in Age-Related Progressing Neurodegenerative Diseases. Drug Metab Rev 2022;:1-17. [PMID: 35038284 DOI: 10.1080/03602532.2022.2029475] [Reference Citation Analysis]
19 Williams KR, Nairn AC. Editorial for Special Issue: Neuroproteomics. Proteomes 2019;7:24. [PMID: 31159207 DOI: 10.3390/proteomes7020024] [Reference Citation Analysis]
20 Kluszczyńska K, Czernek L, Cypryk W, Pęczek Ł, Düchler M. Methods for the Determination of the Purity of Exosomes. Curr Pharm Des 2019;25:4464-85. [PMID: 31808383 DOI: 10.2174/1381612825666191206162712] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
21 Ion L, Petre BA. Immuno-Affinity Mass Spectrometry: A Novel Approaches with Biomedical Relevance. In: Woods AG, Darie CC, editors. Advancements of Mass Spectrometry in Biomedical Research. Cham: Springer International Publishing; 2019. pp. 377-88. [DOI: 10.1007/978-3-030-15950-4_21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Corasolla Carregari V, Monforte M, Di Maio G, Pieroni L, Urbani A, Ricci E, Tasca G. Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy. Int J Mol Sci 2020;22:E290. [PMID: 33396627 DOI: 10.3390/ijms22010290] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
23 Nickerson JL, Baghalabadi V, Rajendran SRCK, Jakubec PJ, Said H, McMillen TS, Dang Z, Doucette AA. Recent advances in top-down proteome sample processing ahead of MS analysis. Mass Spectrom Rev 2021. [PMID: 34047392 DOI: 10.1002/mas.21706] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Guldbrandsen A, Farag YM, Lereim RR, Berven FS, Barsnes H. Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR). Methods Mol Biol 2019;2044:377-91. [PMID: 31432427 DOI: 10.1007/978-1-4939-9706-0_25] [Reference Citation Analysis]
25 Mol MO, Miedema SSM, van Swieten JC, van Rooij JGJ, Dopper EGP. Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics? Int J Mol Sci 2021;22:10298. [PMID: 34638637 DOI: 10.3390/ijms221910298] [Reference Citation Analysis]
26 Hok-a-hin YS, Willemse EAJ, Teunissen CE, Del Campo M. Guidelines for CSF Processing and Biobanking: Impact on the Identification and Development of Optimal CSF Protein Biomarkers. In: Santamaría E, Fernández-irigoyen J, editors. Cerebrospinal Fluid (CSF) Proteomics. New York: Springer; 2019. pp. 27-50. [DOI: 10.1007/978-1-4939-9706-0_2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Lamy R, Farber-Katz S, Vives F, Ayanoglu G, Zhao T, Chen Y, Laotaweerungsawat S, Ma D, Phone A, Psaras C, Li NX, Sutradhar S, Carrington PE, Stewart JM. Comparative Analysis of Multiplex Platforms for Detecting Vitreous Biomarkers in Diabetic Retinopathy. Transl Vis Sci Technol 2020;9:3. [PMID: 32953243 DOI: 10.1167/tvst.9.10.3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H, Dey KK, Chen PC, Yang K, Peng J. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener 2021;16:55. [PMID: 34384464 DOI: 10.1186/s13024-021-00474-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
29 Lachén-montes M, González-morales A, Fernández-irigoyen J, Santamaría E. Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry. In: Santamaría E, Fernández-irigoyen J, editors. Cerebrospinal Fluid (CSF) Proteomics. New York: Springer; 2019. pp. 155-68. [DOI: 10.1007/978-1-4939-9706-0_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Carlyle BC, Kitchen RR, Mattingly Z, Celia AM, Trombetta BA, Das S, Hyman BT, Kivisäkk P, Arnold SE. Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease. Front Neurol 2022;13:889647. [DOI: 10.3389/fneur.2022.889647] [Reference Citation Analysis]
31 Seol W, Kim H, Son I. Urinary Biomarkers for Neurodegenerative Diseases. Exp Neurobiol 2020;29:325-33. [PMID: 33154195 DOI: 10.5607/en20042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]